'Tariff taskforce': Pharma firms scramble to prepare even as Trump levies risk flouting WTO rules

Impact of U.S. Tariffs on European Pharmaceutical Firms: European pharmaceutical companies are forming "tariff taskforces" to prepare for potential 25% tariffs proposed by the U.S. government, which could violate World Trade Organization rules and significantly affect their operations and supply chains.

Concerns Over Domestic Manufacturing and Healthcare Costs: While some firms consider relocating production to the U.S. to mitigate costs, economists warn that such strategies may not be feasible in the short term and could lead to increased prices in the U.S. healthcare system.